Gatica-Ortega, ME, Pastor-Nieto, MA, Giménez-Arnau, AM, Mercader-García, P, Serra-Baldrich, E, Zaragoza-Ninet, V, Sanz-Sánchez, T, Sánchez-Gilo, A, Pesqué, D, Tous-Romero, F, Ortiz-de-Frutos, FJ, de la Rosa-Fernández, E, Dorta-Alom, S, Elosua-González, M, Gonzalez-Perez, R, Carrascosa-Carrillo, JM, Munera-Campos, M, Silvestre-Salvador, JF, Miquel-Miquel, J, Minguez, AD, Borrego, L. An emerging epidemic of allergic contact dermatitis due to phytonadione epoxide (oxidised vitamin K1). CONTACT DERMATITIS. 2024; 91(5)DOI:10.1111/cod.14675. PMID:39164011. IF:4.600(Q1/1D).

Frutos, JOD, Baldrich, ES, Boixareu, MJT, Hita, JCA, Carrillo, JMC, Nart, IF, Flórez, A, Pinto, PH, Silvestre, JF. [Translated article] Consensus on the Diagnostic Algorithm for Chronic Nodular Prurigo. Actas Dermo-Sifiliograficas. 2024; 115(10)DOI:10.1016/j.ad.2024.09.011. PMID:39260612. IF:(Q/D).

Ferrer, AL, Romero, IB, Díaz, RR, Pinto, PH. Four-year maintenance of complete skin clearance with bimekizumab in 10 Spanish patients from the BE RADIANT trial. Actas Dermo-Sifiliograficas. 2024; 115(10)DOI:10.1016/j.ad.2023.05.044. PMID:39033804. IF:(Q/D).

de Frutos, JO, Baldrich, ES, Boixareu, MJT, Hita, JCA, Carrillo, JMC, Nart, IF, Menéndez, AF, Pinto, PH, Silvestre, JF. Consensus on the Diagnostic Algorithm for Chronic Nodular Prurigo. Actas Dermo-Sifiliograficas. 2024; 115(10)DOI:10.1016/j.ad.2024.03.035. PMID:38663729. IF:(Q/D).

Chicharro, P, Munera-Campos, M, Zaragoza-Ninet, V, Giménez-Arnau, A, González-Pérez, R, Miquel-Miquel, FJ, Córdoba-Guijarro, S, Sanz-Sánchez, T, Ruiz-González, I, Silvestre-Salvador, JF, Serra-Baldrich, E, Borrego, L, Pastor-Nieto, MA, de Frutos, FJO, Mercader-García, P, Heras-Mendaza, F, Fernández-Redondo, V, Rodríguez-Serna, M, Hervella-García, M, Carrascosa, JM, Gallego-Descalzo, MA, García-Doval, I, Sánchez-Pérez, J. Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC). CONTACT DERMATITIS. 2024; 91(5)DOI:10.1111/cod.14672. PMID:39138883. IF:4.600(Q1/1D).

Iznardo, H, Roé, E, Vicente, A, Prat, C, Casals, M, Martín-Santiago, A, Esteve, A, Viñas, M, Munera-Campos, M, Corella, F, Mollet, J, Figueras-Nart, I, Vila, A, Soria, X, Azón-Masoliver, A, Marqués-Martín, L, Nadal-Lladó, C, Bel, S, Pujol-Montcusí, J, Bertolín-Colilla, M, Curto-Barredo, L, Melé-Ninot, G, Evole, M, Berbegal, L, Puig, L, Baselga, E. Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospective real-world study. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2024; 50(1)DOI:10.1093/ced/llae300. PMID:39093288. IF:2.800(Q2/4D).

Schwartzman, S, Puig, L, Cohen, AD, Khattri, S, Jossart, C, Diaz, C, Garrelts, A, Ngantcha, M, Eberhart, N, Eleftheriadi, A, Tangsirisap, N, Schuster, C, Gottlieb, AB. Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies. Expert Opinion On Drug Safety. 2024; 23(10)DOI:10.1080/14740338.2024.2399092. PMID:39234767. IF:3.100(Q2/4D).

Stolnicki, DK, Coates, LC, Gollins, CE, Koppikar, S, Perez-Chada, LM, Puig, L, Ogdie, A, Deodhar, A, Ritchlin, C, Hwang, ST, Goldenstein-Schainberg, C. Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic Disease. JOURNAL OF RHEUMATOLOGY. 2024; 51DOI:10.3899/jrheum.2024-0621. PMID:39089830. IF:3.400(Q2/3D).